Results 11 to 20 of about 1,457,629 (200)

Second-generation inhibitors of Bruton tyrosine kinase

open access: yesJournal of Hematology & Oncology, 2016
Bruton tyrosine kinase (BTK) is a critical effector molecule for B cell development and plays a major role in lymphoma genesis. Ibrutinib is the first-generation BTK inhibitor.
Jingjing Wu   +3 more
doaj   +2 more sources

Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas

open access: yesForum of Clinical Oncology, 2017
In normal B-cells, Bruton tyrosine kinase (Btk), a non-receptor tyrosine kinase involved in B-cell receptor (BCR) signalling, is essential for cell survival and maturation. Not surprisingly, Btk is also implicated in the pathogenesis of B-cell lymphomas,
Sklavenitis-Pistofidis R.   +3 more
doaj   +3 more sources

P1006: CHARACTERIZATION OF TL-895: A NOVEL BRUTON TYROSINE KINASE INHIBITOR (BTKI) IN CLINICAL DEVELOPMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MYELOFIBROSIS (MF) [PDF]

open access: yesHemaSphere, 2023
Michael Gulrajani   +8 more
doaj   +2 more sources

The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact [PDF]

open access: yesHaematologica, 2022
Jonathan J. Pinney   +11 more
doaj   +2 more sources

Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy [PDF]

open access: yesBlood Cancer Journal
Karan L. Chohan   +13 more
doaj   +2 more sources

P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL) [PDF]

open access: yesHemaSphere, 2023
Michael Loschi   +17 more
doaj   +2 more sources

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

open access: yesFrontiers in Oncology, 2021
Posttransplant lymphoproliferative disorder (PTLD) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with poor prognosis.
Ting-Ting Yang   +17 more
doaj   +1 more source

Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton\u27s Tyrosine Kinase Inhibitors [PDF]

open access: yes, 2023
Bruton\u27s tyrosine kinase (BTK) is a promising molecular target for several human B-cell-related autoimmune disorders, inflammation, and haematological malignancies.
Marián , Hajdúch   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy